Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial<\/h3>

Cascales Campos Pedro Antonio, MD, PHD, Gonzalez Gil Alida, MD, PHD, Gil Gomez Elena, MD, PH1,Gonzalez Sanchez Rocio, PHD, Mart\u0131nez Garcia Jeronimo, MD, PHD, Alonso Romero Jose Luis, MD, PHD, Nieto Diaz Anibal, MD, PHD, Barcelo Valcarcel Francisco, MD, PHD, Gomez Ruiz Alvaro Jesus, MD, PHD,Ramirez Romero Pablo, MD, PHD, and Gil Martinez Jose, MD, PHD<\/p>Read Abstract <\/i><\/a><\/div>

Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer<\/h3>

Ziying Lei, MD; Yue Wang, MD; Jiahong Wang, MD; Ke Wang, MD; Jun Tian, MD; Ying Zhao, MD; Lipai Chen, MD; Jin Wang, MD; Jiali Luo, PhD; Manman Jia, MD;Hongsheng Tang, MD; Qingjun He, MD; Quanxing Liao, MD; Xiansheng Yang, MD; Tianpei Guan, MD; Li Wang, MD; Shuzhong Cui, MD, PhD;<\/p>Read Abstract <\/i><\/a><\/div>

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis<\/h3>

Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang<\/p>Read Abstract <\/i><\/a><\/div>

Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis<\/h3>

Se Ik Kim, MD, Jaehyun Cho, MD, Eun Ji Lee, MD, Sunwoo Park, BS, Soo Jin Park, MDa,Aeran Seol, MD, Nara Lee, MD, Ga Won Yim, MD, PhD, Maria Lee, MD, PhD, Whasun Lim, PhD,Gwonhwa Song, PhD, Suk Joon Chang, MD, PhD, Jae Won Kim, MD, PhD, Hee Seung Kim, MD, PhD<\/p>Read Abstract <\/i><\/a><\/div>

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy<\/h3>

Stephanie L.Lima, Laura J.Havrilesky, Ashraf S.Habib, Angeles Alvarez Secord<\/p>Read Abstract <\/i><\/a><\/div>

Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial<\/h3>

Simone N. Koole, MD; Christiaan van Lieshout, MSc; Willemien J. van Driel, PhD, MD; Evi van Schagen, MSc;Karolina Sikorska, PhD; Jacobien M. Kieffer, PhD; Jules H. Schagen van Leeuwen, MD, PhD; Henk W.R. Schreuder, MD, PhD;Ralph H. Hermans, MD, PhD; Ignace H. de Hingh, MD, PhD; Jacobus van der Velden, PhD, MD; Henriette J. Arts, MD, PhD;Leon F.A.G. Massuger, MD, PhD; Arend G. Aalbers, MD; Victor J. Verwaal, MD, PhD; Koen K. Van de Vijver, MD, PhD;Neil K. Aaronson, PhD; Harm van Tinteren, PhD; Gabe S. Sonke, MD, PhD; Wim H. van Harten, MD, PhD;andValesca P. Ret`el, PhD<\/p>Read Abstract <\/i><\/a><\/div>

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer<\/h3>

W.J. van Driel, S.N. Koole, K. Sikorska, J.H. Schagen van Leeuwen, H.W.R. Schreuder, R.H.M. Hermans, I.H.J.T. de Hingh, J. van der Velden, H.J. Arts, L.F.A.G. Massuger, A.G.J. Aalbers, V.J. Verwaal, J.M. Kieffer, K.K. Van de Vijver, H. van Tinteren, N.K. Aaronson, and G.S. Sonke<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study<\/h3>

J. Spiliotis, MD, PhD, E. Halkia, MD, PhD, E. Lianos, MD, N. Kalantzi, MD, A. Grivas, MD, E. Efstathiou, MD, and S. Giassas, MD<\/p>Read Abstract <\/i><\/a><\/div>

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy<\/h3>

Daniel L Chan, David L Morris, Archana Rao, Terence C Chua<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients<\/h3>

N. Bakrin, MD, E. Cotte, MD, F. Golfier MD, PhD, F. N. Gilly, MD, PhD, G. Freyer, MD, PhD, W. Helm, MD,PhD, O. Glehen, MD, PhD, and J. M. Bereder, MD<\/p>Read Abstract <\/i><\/a><\/div>

HIPEC in recurrent ovarian cancer patients: Morbidity-related treatment andlong-term analysis of clinical outcome<\/h3>

Anna Fagotti, Barbara Costantini, Giuseppe Vizzielli, Federica Perelli, Alfredo Ercoli,Valerio Gallotta, Giovanni Scambia, Francesco Fanfani<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial<\/h3>

Marcello Deraco<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Shigeki Kusamura<\/a>,\u00a0<\/span><\/span>Salvatore Virz\u00ec<\/a>,\u00a0<\/span><\/span>Francesco Puccio<\/a>,\u00a0<\/span><\/span>Antonio Macr\u00ec<\/a>,\u00a0<\/span><\/span>Ciro Famulari<\/a>,\u00a0<\/span><\/span>Massimiliano Solazzo<\/a>,\u00a0<\/span><\/span>Serena Bonomi<\/a>,\u00a0<\/span><\/span>Domenico Rosario Iusco<\/a>,\u00a0<\/span><\/span>Dario Baratti<\/a><\/span><\/p>Read Abstract <\/i><\/a><\/div><\/div>[\/vc_column_text][\/vc_tab][vc_tab title=”HIPEC NEL TUMORE GASTRICO” tab_id=”1475242307-2-12″][vc_column_text]

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of \u2018Italian Peritoneal SurfaceMalignancies Oncoteam\u2014S.I.C.O.'<\/h3>

Luigi Marano, MD, PhD, Daniele Marrelli, MD, Paolo Sammartino, MD, PhD, Daniele Biacchi, MD, PhD,Luigina Graziosi, MD, PhD, Elisabetta Marino, MD, Federico Coccolini, MD, Paola Fugazzola, MD, Mario Valle, MD, Orietta Federici, MD, Dario Baratti, MD, Marcello Deraco, MD, Andrea Di Giorgio, MD, Antonio Macr\u00ec, MD, Enrico Maria Pasqual, MD, Massimo Framarini, MD, PhD, Marco Vaira, MD, Franco Roviello, MD<\/p>Read Abstract <\/i><\/a><\/div>

A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology<\/h3>

Brian Badgwell, MD, MS, Naruhiko Ikoma, MD, MS, Mariela Blum Murphy, MD, Xuemei Wang, MS,Jeannelyn Estrella, MD, Sinchita Roy-Chowdhuri, MD, PhD, Prajnan Das, MD, Bruce D. Minsky, MD,Elizabeth Lano, MD, Shumei Song, PhD, Paul Mansfield, MD, and Jaffer Ajani, MD<\/p>Read Abstract <\/i><\/a><\/div>

Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study<\/h3>

Maneesh Kumarsing Beeharry, Zheng-Lun Zhu, Wen-Tao Liu, Xue-Xin Yao*, Min Yan and Zheng-Gang Zhu<\/p>Read Abstract <\/i><\/a><\/div>

Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of therandomized controlled trials<\/h3>

Yan-Wen Liu, Ying Du and Bao-An Chen<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis<\/h3>

Pierre-Emmanuel Bonnot, MD; Guillaume Piessen, MD, PhD; Vahan Kepenekian, MD; Evelyne Decullier, PhD;Marc Pocard, MD, PhD; Bernard Meunier, PhD; Jean-Marc Bereder, MD; Karine Abboud, MD; Frederic Marchal, MD, PhD;Fran\u00e7ois Quenet, MD; Diane Goere, MD, PhD; Simon Msika, MD, PhD; Catherine Arvieux, MD, PhD; Nicolas Pirro, MD, PhD;Romuald Wernert, MD; Patrick Rat, MD, PhD; Johan Gagniere, MD, PhD; Jeremie H. Lefevre, MD, PhD; Thomas Courvoisier, MD;Reza Kianmanesh, MD, PhD; Delphine Vaudoyer, MD; Michel Rivoire, MD, PhD; Pierre Meeus, MD;Guillaume Passot, MD, PhD and Olivier Glehen, MD, PhD<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)<\/h3>

Israel Manzanedo, MD, Fernando Pereira, MD, PhD, Cristina Rihuete Caro, MD, Estibalitz Perez-Viejo, MD, PhD, Angel Serrano, MD, PhD, Alberto Gutierrez Calvo, MD, Fernando M. Regueira, MD, Angela Casado-Adam, MD, Pedro A. Cascales-Campos, MD, PhD, Xabier Arteaga, MD, Alfonso Garcia-Fadrique, MD, Remedios Gomez Sanz, MD, Adela Lopez Garcia, MD, Gabriel Zozaya, MD,Alvaro Arjona, MD, and Jose Gil Martinez, MD<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial<\/h3>

Baki Topal, Karel Demey, Halit Topal, Joris Jaekers, Eric Van Cutsem, Vincent Vandecaveye, Xavier Sagaert and Hans Prenen<\/p>Read Abstract <\/i><\/a><\/div>

Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvantchemotherapy for advanced gastric cancer patients with serosal invasion<\/h3>

Lung-Yun Kang, King-Tong Mok, Shiuh-Inn Liu, Cheng-Chong Tsai, Being-Whey Wang,I-Shu Chen, Yu-Chia Chen, Bo-Min Chang, Nan-Hua Chou<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial<\/h3>

Xiao-Jun Yang, MD, Chao-Qun Huang, MD, Tao Suo, MD, Lie-Jun Mei, MD, Guo-Liang Yang, MD,Fu-Lin Cheng, MD, Yun-Feng Zhou, MD, PhD, Bin Xiong, MD, PhD, Yutaka Yonemura, MD, PhD,and Yan Li, MD, PhD<\/p>Read Abstract <\/i><\/a><\/div>

Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy<\/h3>

Olivier Glehen, MD, PhD, Franc \u0327ois Noel Gilly, MD, PhD, Catherine Arvieux, MD, PhD, Eddy Cotte, MD,Florent Boutitie, Baudouin Mansvelt, MD, PhD, Jean Marc Bereder, MD, Gerard Lorimier, MD, Francois Quenet, MD, Dominique Elias, MD, PhD<\/p>Read Abstract <\/i><\/a><\/div><\/div>[\/vc_column_text][\/vc_tab][vc_tab title=”HIPEC NEL TUMORE DEL COLON-RETTO ” tab_id=”1475242307-1-97″][vc_column_text]

The Current Practice of Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)<\/h3>

Bushati M, MD; Rovers KP, MD; Sommariva A, MD; Sugarbaker PH, MD; Morris DL, MD, PhD; Yonemura Y, MD, PhD; Quadros CA, MD, PhD; Somashekhar SP, MD, PhD; Ceelen W, MD, PhD; Dub\u00e9 P, MD; LI Y, MD, PhD; Verwaal VJ, MD, PhD; Glehen O, MD, PhD; Piso P, MD, PhD; Spiliotis J, MD, PhD; Teo MCC, MD, PhD; Gonz\u00e1lez-Moreno S, MD, PhD; Cashin PH, MD, PhD; Lehmann K, MD, PhD; Deraco M, MD; Moran B, MD, PhD; de Hingh IHJT, MD, PhD<\/p>Read Abstract <\/i><\/a><\/div>

Perioperative systemic chemotherapy, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal peritoneal metastasis: results of the prospective multicenter phase II COMBATAC trial<\/h3>

Gabriel Glockzin, Florian Zeman, Roland S. Croner, Alfred K\u00f6nigsrainer, J\u00f6rg Pelz, Michael A. Str\u00f6hlein, Beate Rau, Dirk Arnold, Michael Koller, Hans J. Schlitt, Pompiliu Piso<\/p>Read Abstract <\/i><\/a><\/div>

Benefit of cytoreductive surgery combined with hyperthermicintraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer<\/h3>

mpiliu Piso, Kathrin Stierstorfer, Michael Gerken, Monika Klinkhammer-Schalke<\/p>Read Abstract <\/i><\/a><\/div>

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases<\/h3>

Dario Baratti<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Shigeki Kusamura<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Domenico Iusco<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Silvia Gimondi<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Filippo Pietrantonio<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Massimo Milione<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Marcello Guaglio<\/a>,\u00a0<\/span><\/span>Serena Bonomi<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Antonio Grassi<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Salvatore Virz\u00ec<\/a>^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>}Ermanno Leo<\/a>,\u00a0<\/span><\/span>Marcello Deraco<\/a>^{\u00a0<\/span><\/sup><\/span><\/p>}Read Abstract <\/i><\/a><\/div>

Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands<\/h3>

L.G.E.M. Razenberga,b, Y.R.B.M. van Gestelb, G.-J. Creemersa,V.J. Verwaalc, V.E.P.P. Lemmensb,d, I.H.J.T. de Hing<\/p>Read Abstract <\/i><\/a><\/div>

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with ColorectalCancer with Peritoneal Carcinomatosis<\/h3>

Jesus Esquivel, MD, Andrew M. Lowy, MD, Maurie Markman, MD, Terence Chua, MD, Joerg Pelz, MD, Dario Baratti, MD, Joel M. Baumgartner, MD, Richard Berri, MD, Pedro Bretcha-Boix, MD, Marcello Deraco,MD, Guillermo Flores-Ayala, MD, Olivier Glehen, MD, Alberto Gomez-Portilla, MD, Santiago Gonzalez-Moreno, MD, Martin Goodman, MD, Evgenia Halkia, MD, Shigeki Kusamura, MD, Mecker Moller, MD,Guillaume Passot, MD, Marc Pocard, MD, George Salti, MD, Armando Sardi, MD, Maheswari Senthil,MD, John Spilioitis, MD, Juan Torres-Melero, MD, Kiran Turaga, MD, and Richard Trout, PhD<\/p>Read Abstract <\/i><\/a><\/div>

Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC)in Colorectal Cancer Patients in the United States<\/h3>

K. Turaga, E. Levine, R. Barone, R. Sticca, N. Petrelli, L. Lambert, G. Nash, M. Morse, R. Adbel-Misih, H. R. Alexander, F. Attiyeh, D. Bartlett, A. Bastidas, T. Blazer, Q. Chu, K. Chung, L. Dominguez-Parra, N. J. Espat, J. Foster, K. Fournier, R. Garcia, M. Goodman, N. Hanna, L. Harrison, R. Hoefer, M. Holtzman, J. Kane, D. Labow, B.Li, A. Lowy, P. Mansfield, E. Ong, C. Pameijer, J. Pingpank, M. Quinones, R. Royal, G. Salti, A. Sardi, P. Shen, J. Skitzki, J. Spellman, J. Stewart, and J. Esquivel<\/p>Read Abstract <\/i><\/a><\/div>

Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis<\/h3>

D Elias, MD, PhD, C Honore, MD, F Dumont, MD,M. Ducreux, MD, PhD, V. Boige, MD, PhD, D. Malka, MD, PhD, P. Burtin, MD, C. Dromain, MD, and D. Goere, MD<\/p>Read Abstract <\/i><\/a><\/div>

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin<\/h3>

Dominique Elias<\/a><\/span>\u00a0,\u00a0J\u00e9r\u00e9mie H. Lefevre<\/a><\/span>\u00a0,\u00a0Julie Chevalier<\/a><\/span>\u00a0,\u00a0Antoine Brouquet<\/a><\/span>\u00a0,\u00a0Fr\u00e9d\u00e9ric Marchal<\/a><\/span>\u00a0,\u00a0Jean-Marc Classe<\/a>,\u00a0<\/span><\/span>Gwena\u00ebl Ferron<\/a><\/span>\u00a0,\u00a0Jean-Marc Guilloit<\/a><\/span>\u00a0,\u00a0Pierre Meeus<\/a><\/span>\u00a0,\u00a0Diane Go\u00e9r\u00e9<\/a><\/span>\u00a0,\u00a0Julia Bonastre<\/a><\/span><\/span><\/p>Read Abstract <\/i><\/a><\/div>

Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer<\/h3>

Vic J. Verwaal, Serge van Ruth, Eelco de Bree, Gooike W. van Slooten, Harm van Tinteren, Henk Boot and Frans A.N. Zoetmulder<\/p>Read Abstract <\/i><\/a><\/div><\/div>[\/vc_column_text][\/vc_tab][vc_tab title=”HIPEC NEL MESOTHELIOMA PERITONEALE” tab_id=”1478103224031-3-5″][vc_column_text]

Well differentiated papillary peritoneal mesothelioma treated by cytoreduction andhyperthermic intraperitoneal chemotherapy - the experience of the PSOGI registry<\/h3>

Marcello Deraco, Eran Nizri, Olivier Glehen, Dario Baratti, Jean-Jacques Tuech,Jean-Marc Bereder, Vahan Kepenekian, Shigeki Kusamura, Diane Goere<\/p>Read Abstract <\/i><\/a><\/div>

Multicystic mesothelioma: operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy<\/h3>

Eran Nizri, Dario Baratti, Marcello Guaglio, Snita Sinukumar, Antonello Cabras,Shigeki Kusamura, Marcello Deraco<\/p>Read Abstract <\/i><\/a><\/div>

Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma<\/h3>

H. Richard Alexander, Jr, MD, David L. Bartlett, MD, James F. Pingpank, MD, Steven K. Libutti, MD, Richard Royal, MD, Marybeth S. Hughes, MD, Matthew Holtzman, MD, Nader Hanna, MD, Keli Turner, MD, Tatiana Beresneva, MD, and Yue Zhu, MD, MS<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study<\/h3>

Dario Baratti, MD, Shigeki Kusamura, PhD, Antonello Domenico Cabras, MD, and Marcello Deraco, MD<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma<\/h3>

Aaron U. Blackham, M.D. and Edward A. Levine, M.D.<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive Surgery and Hyperthermic IntraperitonealChemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience<\/h3>

Tristan D. Yan, Marcello Deraco, Dario Baratti, Shigeki Kusamura, Dominique Elias, Olivier Glehen, Francois N. Gilly, Edward A. Levine, Perry Shen, Faheez Mohamed, Brendan J. Moran, David L. Morris,Terence C. Chua, Pompiliu Piso, and Paul H. Sugarbaker<\/p>Read Abstract <\/i><\/a><\/div>

Consensus Statement on Peritoneal Mesothelioma<\/h3>

MARCELLO DERACO,MD, DAVID BARTLETT, SHIGEKI KUSAMURA,MD, AND DARIO BARATTI,MD<\/p>Read Abstract <\/i><\/a><\/div><\/div>[\/vc_column_text][\/vc_tab][vc_tab title=”HIPEC NELLO PSEUDOMIXOMA” tab_id=”1478103341972-6-8″][vc_column_text]

The Role of Hyperthermic Intraperitoneal Chemotherapyin Pseudomyxoma Peritonei After Cytoreductive Surgery<\/h3>

Shigeki Kusamura, MD, PhD; Francesco Barretta, PhD; Yutaka Yonemura, MD, PhD; Paul Hendrick Sugarbaker, MD; Brendan John Moran, MCh;Edward A. Levine, MD; Diane Goere, MD, PhD; Dario Baratti, MD; Eran Nizri, MD, PhD; David Lawson Morris, MB, ChB, MD, PhD; Olivier Glehen, MD, PhD;Armando Sardi, MD; Pedro Barrios, MD; Fran\u00e7ois Qu\u00e9net, MD, PhD; Laurent Villeneuve, MBE, PhD; Alberto G\u00f3mez-Portilla, MD, PhD;Ignace de Hingh, MD, PhD; Wim Ceelen, MD, PhD; Joerg O. W. Pelz, MD; Pompiliu Piso, MD, PhD; Santiago Gonz\u00e1lez-Moreno, MD, PhD;Kurt Van Der Speeten, MD, PhD; Marcello Deraco, MD;<\/p>Read Abstract <\/i><\/a><\/div>

Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme<\/h3>

Rebecca Fish, Andrew G Renehan, Grant Punnett, Omer Aziz, Paul Fulford, Chelliah Selvasekar, Malcolm Wilson, Rebecca Halstead, Sarah T. O\u2019Dwyer<\/p>Read Abstract <\/i><\/a><\/div>

Long-term survival after aggressive treatment of relapsedserosal or distant pseudomyxoma peritonei<\/h3>

J.-B. Delhorme, C. Honore, L. Benhaim, F. Dumont, ,P. Dartigues, C. Dromain, M. Ducreux, D. Elias, D.Goer<\/p>Read Abstract <\/i><\/a><\/div>

Outcome differences between debulking surgery and cytoreductive surgeryin patients with pseudomyxoma peritonei<\/h3>

H. Andreasson, W. Graf, P. Nygren, B. Glimelius,c, H. Mahteme<\/p>Read Abstract <\/i><\/a><\/div>

Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy<\/h3>

Terence C. Chua, Brendan J. Moran, Paul H. Sugarbaker, Edward A. Levine, Olivier Glehen, Franc ois N. Gilly, Dario Baratti, Marcello Deraco, Dominique Elias, Armando Sardi, Winston Liauw, Tristan D. Yan,Pedro Barrios, Alberto Gomez Portilla, Ignace H.J.T. de Hingh, Wim P. Ceelen, Joerg O. Pelz, Pompiliu Piso,\u00a0Santiago Gonzalez-Moreno, Kurt Van Der Speeten, and David L. Morris<\/p>Read Abstract <\/i><\/a><\/div>

Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy<\/h3>

D. Elias,\u00a0<\/span><\/span>F. Gilly,\u00a0<\/span><\/span>F. Quenet,\u00a0<\/span><\/span>J. M. Bereder,\u00a0<\/span><\/span>L. Sid\u00e9ris,\u00a0<\/span><\/span>B. Mansvelt,\u00a0<\/span><\/span>G. Lorimier,\u00a0<\/span><\/span>O. Glehen<\/span><\/p>Read Abstract <\/i><\/a><\/div><\/div>[\/vc_column_text][\/vc_tab][vc_tab title=”HIPEC IN PAZIENTI PEDIATRICI” tab_id=”1478103310158-5-10″][vc_column_text]

Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial<\/h3>

Andrea A. Hayes-Jordan, MD, Brian A. Coakley, MD, Holly L. Green, PA-C, LianChun Xiao, MS, Keith F. Fournier, MD, Cynthia E. Herzog, MD, Joseph A. Ludwig, MD, Mary F. McAleer, MD PhD, Peter M. Anderson, MD PhD, and Winston W. Huh, MD<\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A safe treatment option for intraperitoneal rhabdomyosarcoma in children below 5 years of age<\/h3>

Jens Gesche<\/i>,\u00a0<\/span><\/span>Stefan Beckert,\u00a0<\/span><\/span>Felix Neunhoeffer,\u00a0<\/span><\/span>Denis Kachanov,\u00a0<\/span><\/span>Alfred K\u00f6nigsrainer,\u00a0<\/span><\/span>Guido Seitz,\u00a0<\/span><\/span>J\u00f6rg Fuchs<\/span><\/p>Read Abstract <\/i><\/a><\/div>

Cytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: A French nation wide study over 14 years<\/h3>

Aur\u00e9lien Scalabre^{\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>Pascale Philippe-Chomette,\u00a0<\/span><\/span>Guillaume Passot,\u00a0<\/span><\/span>Daniel Orbach\u00a0<\/span><\/sup>,\u00a0<\/span><\/span>Dominique Elias,\u00a0<\/span><\/span>Nad\u00e8ge Corradini,\u00a0<\/span><\/span>Laurence Brugi\u00e8res,\u00a0<\/span><\/span>Simon Msika,\u00a0<\/span><\/span>Marc-David Leclair,\u00a0<\/span><\/span>Sol\u00e8ne Joseph,\u00a0<\/span><\/span>C\u00e9cile Brigand,\u00a0<\/span><\/span>Fran\u00e7ois Becmeur,\u00a0<\/span><\/span>Christine Soler,\u00a0<\/span><\/span>Denis Pezet,\u00a0<\/span><\/span>Johan Gagniere,\u00a0<\/span><\/span>Olivier Glehen,\u00a0<\/span><\/span>Sabine Sarnacki<\/span><\/p>}Read Abstract <\/i><\/a><\/div><\/div>[\/vc_column_text][\/vc_tab][\/vc_tabs][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading heading_semantic=”h1″ text_size=”h1″ text_weight=”300″]PUBBLICAZIONI[\/vc_custom_heading][vc_tabs vertical=”yes”][vc_tab title=”HIPEC NEL TUMORE DELL\u2019OVAIO” tab_id=”1478103286103-4-5″][vc_column_text][\/vc_column_text][\/vc_tab][vc_tab title=”HIPEC NEL TUMORE GASTRICO” tab_id=”1475242307-2-12″][vc_column_text][\/vc_column_text][\/vc_tab][vc_tab title=”HIPEC NEL TUMORE DEL COLON-RETTO […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":2340,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2312","page","type-page","status-publish","hentry"],"yoast_head":"\n